A 3-Protein Expression Signature of Neuroblastoma for Outcome Prediction

In conclusion, we established a robust risk assessment predictor model based on simple immunohistochemistry for therapeutic decisions of NB patients.
Source: The American Journal of Surgical Pathology - Category: Pathology Tags: Original Articles Source Type: research